- Oral presentation
- Open Access
XACT, a long non-coding transcript coating the active X chromosome in human pluripotent cells
Epigenetics & Chromatin volume 6, Article number: O33 (2013)
X-chromosome inactivation (XCI), the dosage compensation process that equalizes X-linked gene expression between sexes, has mostly been studied in the mouse, where the central role for the non-coding RNA Xist in the initiation and spreading of the process was demonstrated. Although Xist is conserved in humans , very little is known concerning its regulation and function in this species. Several lines of evidence moreover suggest that different strategies have been adopted in the human to control XCI as compared to the mouse. In particular, in human pre-implantation development, XIST RNA coats the X chromosome(s) in both male and female embryos without inducing X-chromosome silencing . This indicates that XIST expression and X-inactivation can be uncoupled during human embryogenesis and that other elements likely participate to the control of X chromosome activity in humans.
XCI is established early during embryonic development, and embryonic stem cells can be used to decipher the kinetics and the molecular actors of the process. Human female embryonic stem cells (hESC) can be found in different configurations regarding XIST expression: most female hESC have already undergone XCI but tend to spontaneously lose XIST expression . In the course of an RNA-seq analysis of female hESC, we identified an extended and un-annotated transcribed region producing a long unspliced, likely non-coding nuclear RNA. RNA-FISH analysis reveals that this transcript is expressed from, and coats the active X chromosome. We called this transcript XACT, for X-active coating transcript. In female hESC in which XIST is repressed, XACT is expressed from and coats both Xs, and this correlates with significant reactivation of the inactive X chromosome. Expression of XACT appears to be specific for pluripotent cells as its expression decreases during differentiation. Finally, we provide evidence that XACT is not conserved in the mouse.
In conclusion, we have identified XACT as the first long ncRNA that coats the active X chromosome in human. Given its expression profile and lack of conservation, it is tempting to speculate that XACT is involved in the peculiar control of XCI initiation in human.
Brown CJ, Lafreniere RG, Powers VE, Sebastio G, Ballabio A, Pettigrew AL, Ledbetter DH, Levy E, Craig IW, Willard HF: Localization of the X inactivation centre on the human X chromosome in Xq13. Nature. 1991, 34: 82-84.
Okamoto I, Patrat C, Thepot D, Peynot N, Faugue P, Daniel N, Diabangouaya P, Wolf JP, Renard JP, Duranthon V, Heard E: Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature. 2011, 472: 370-374. 10.1038/nature09872.
Makhlouf M, Rougeulle C: Linking X chromosome inactivation to pluripotency: Necessity or Fate?. Trend Mol Med. 2011, 17: 326-336.
About this article
Cite this article
Vallot, C., Huret, C., Lesecque, Y. et al. XACT, a long non-coding transcript coating the active X chromosome in human pluripotent cells. Epigenetics & Chromatin 6, O33 (2013). https://doi.org/10.1186/1756-8935-6-S1-O33
- Embryonic Stem Cell
- Pluripotent Cell
- Dosage Compensation
- Female Embryo
- XIST Expression